UK Listings Review: Do New Recommendations Change The Game For Tech And Life Sciences Companies?

Published date16 March 2021
Subject MatterLife Sciences,Emerging Growth Companies,Publicly-Traded Companies,Financial Statements,Capital Markets,Emerging Technology Companies,London Stock Exchange,UK,Listing Rules,Initial Public Offerings,Dual Class Share Structures,Special Purpose Acquisition Companies (SPACs)
AuthorDavid Mardle,Markus Bauman
Law FirmGoodwin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT